Galaxy MedicareShare price, financial results, shareholding and management
- Market cap
- ₹27 cr
- Stock P/E
- 7.9peers 25.3
- Book value
- ₹26.6
- Price to book
- 0.67
- EV / operating profit
- 4.2
- Market cap to sales
- 0.67
- ROCE · FY26
- 13.6%
- ROE · FY26
- 10.6%
- ROE, 3-year average
- 14.8%
- Operating margin · FY26
- 10.6%peers 14.9%
- Sales growth, 3 years
- 8.9%
- Profit growth, 3 years
- 29.6%
- Debt to equity
- 0.10peers 0.11
- Borrowings
- ₹4.2 cr
- Interest cover
- 17.8×
- Cash from business / op. profit
- 42%
- Debtor days
- 70
- Pledged
- 0.00%
- Promoter holding
- 73.36%
- Change in promoter holding
- +0.38 pts
- Shareholders
- 821
- 52-week high / low
- ₹24 / ₹15
- Dividend yield
- Paid
- Face value
- ₹10
Tap or hover on any figure for what it means. Our arithmetic on reported figures, at the latest close.
newboard is reading this company's filings. Its plain description, key points, management and study will appear here soon; the figures below are worked out from what it has filed.
Galaxy Medicare share price chart
Close on 3 Nov 2026 · -1.67% on the day · Vol 20,000
Daily prices to 3 Nov 2026, adjusted for splits and bonuses. Closing prices only: check the exchange for the live price.
Share price returns
To the close of 3 Nov 2026
- 1 month
- +4.1%
- 3 months
- +6.0%
- 6 months
- -11.3%
- 1 year
- -19.2%
- Since IPO
- -67.2%
- Traded a day, 20 days
- ₹0.02 cr
- Taken for delivery
- 90%
Business growth
Sales and net profit, from the reported results
| Sales | Profit | |
|---|---|---|
| FY26 on FY25 | +3% | +1% |
| 3 years, a year | +9% | +30% |
| Latest half, H2 FY26 | -3% | -16% |
Galaxy Medicare revenue and profit growth
Half-yearly results · Profit and lossSales have grown steadily. Last year profit grew roughly in step with sales.
SME companies report every six months. In the latest half, sales were lower than in the same half a year before. Profit grew more slowly than sales, so each rupee of sales left a little less profit.
Galaxy Medicare half-yearly results
SME companies report every six months · ₹ crore
| H1FY25 | H2FY25 | H1FY26 | H2FY26 | |
|---|---|---|---|---|
| Sales | 17.24 | 21.96 | 18.73 | 21.27 |
| Expenses | 14.74 | 19.81 | 15.88 | 19.90 |
| Operating profit | 2.50 | 2.15 | 2.86 | 1.37 |
| OPM | 14.5% | 9.8% | 15.3% | 6.4% |
| Interest | 0.38 | 0.31 | 0.11 | 0.16 |
| Depreciation | 0.25 | 0.25 | 0.30 | 0.25 |
| Profit before tax | 2.42 | 2.11 | 2.78 | 1.93 |
| Net profit | 1.71 | 1.66 | 2.02 | 1.40 |
Galaxy Medicare profit and loss
Full years to March, FY21 to FY26 · ₹ crore, consolidated where reported
| FY21 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Sales | 28.57 | 30.94 | 35.84 | 38.86 | 40 |
| Expenses | 26.41 | 28.59 | 30.87 | 34.16 | 35.78 |
| Operating profit | 2.16 | 2.35 | 4.97 | 4.70 | 4.23 |
| OPM | 7.6% | 7.6% | 13.9% | 12.1% | 10.6% |
| Other income | 0.50 | 1.72 | 1.18 | 1.07 | 1.31 |
| Interest | 0.80 | 0.95 | 0.94 | 0.74 | 0.28 |
| Depreciation | 0.82 | 1.12 | 0.48 | 0.50 | 0.55 |
| Profit before tax | 1.04 | 2 | 4.73 | 4.53 | 4.71 |
| Tax rate | 30.8% | 21.5% | 21.6% | 25.6% | 27.4% |
| Net profit | 0.72 | 1.57 | 3.71 | 3.37 | 3.42 |
| EPS ₹ | 2.57 | 5.16 | 3.13 | 2.84 | 2.25 |
| Dividend payout | 9.7% | 0.0% | 0.0% | 26.4% | 31.1% |
Galaxy Medicare profitability
Margins and returns on capitalLast year the company kept about as much from each rupee of sales as the year before. It earns a moderate return on the money it uses.
Operating margin, every year
Per cent of sales kept before interest, depreciation and tax
| FY21 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Operating margin | 7.6% | 7.6% | 13.9% | 12.1% | 10.6% |
| Tax rate | 30.8% | 21.5% | 21.6% | 25.6% | 27.4% |
| ROCE | · | 11.5% | 20.1% | 18.1% | 13.6% |
| ROE | · | 9.4% | 18.9% | 14.8% | 10.6% |
| Dividend payout | 9.7% | 0.0% | 0.0% | 26.4% | 31.1% |
Galaxy Medicare debt and cash flow
Balance sheet · Cash flow · Working capitalThe company's own money, its net worth, has grown fast. Its loans are smaller than its own money. Last year the business brought in less cash than it showed as profit, so part of the profit is still to be collected. It spent more on assets and investments than the business brought in, and raised the rest from loans or shares. Customers take about as long to pay as they did in FY24.
Bars below the line are cash going out.
Galaxy Medicare balance sheet
At each 31 March · ₹ crore
| FY21 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Equity capital | 2.80 | 3.04 | 11.86 | 11.86 | 15.17 |
| Reserves | 12.88 | 14.78 | 9.51 | 12.29 | 25.17 |
| Net worth | 15.68 | 17.82 | 21.37 | 24.15 | 40.34 |
| Borrowings | 8.78 | 9.15 | 8.12 | 4.61 | 4.20 |
| Other liabilities | 5.44 | 5.34 | 3.05 | 2.73 | 4.23 |
| Total liabilities | 29.90 | 32.31 | 32.54 | 31.49 | 48.77 |
| Fixed assets | 13.95 | 14.57 | 14.41 | 14.13 | 15.03 |
| Capital work in progress | 0.20 | 0.06 | 0 | 0 | 0 |
| Investments | 2.98 | 2.69 | 3.11 | 2.82 | 2.87 |
| Other assets | 12.77 | 14.99 | 15.02 | 14.54 | 30.87 |
| Receivables | · | · | · | · | 7.62 |
| Inventory | · | · | · | · | 5.62 |
| Cash | · | · | · | · | 13.22 |
| Trade payables | · | · | · | · | 2.49 |
Galaxy Medicare cash flow
₹ crore
| FY21 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Cash from operations | 5.56 | 3.65 | 2.71 | 4.49 | 1.77 |
| Cash from investing | -4.46 | -1.91 | -0.65 | 0.32 | -13.90 |
| Cash from financing | -1.11 | -1.80 | -2.08 | -4.72 | 12.09 |
| Net cash flow | -0.01 | -0.06 | -0.02 | 0.09 | -0.04 |
| Capital spending | · | · | · | · | 1.60 |
Working capital
Days
| FY21 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Debtor days | 93 | 107 | 75 | 65 | 70 |
| Inventory days | 74 | 101 | 124 | 85 | 99 |
| Days payable | 102 | 92 | 32 | 22 | 44 |
| Cash conversion cycle | 66 | 116 | 166 | 127 | 125 |
| Working capital days | 1 | 36 | 57 | 69 | 95 |
Galaxy Medicare peers and competitors
Listed SME companies in the same industryBy sales, Galaxy Medicare is number 13 of the 15 listed SME companies in healthcare equipment & supplies.
Each company's latest full year and its latest close; companies the exchange puts in the same industry, whose businesses can differ a good deal. A list, not a comparison of their shares.
| Company | Market cap ₹ cr | P/E | Sales ₹ cr | Profit ₹ cr | Op. margin | Debt/equity |
|---|---|---|---|---|---|---|
| Mohini Health & Hygiene | 57 | - | 144 | -16.7 | -1.8% | 0.39 |
| Vaidya Sane Ayurved Laboratories | 177 | 19.7 | 107 | 9 | 14.4% | 0.04 |
| Royal Sense | 39 | 5.5 | 103 | 7 | 11.0% | 0.33 |
| Prevest Denpro | 472 | 23.6 | 72 | 20 | 35.0% | 0.00 |
| Aprameya Engineering | 187 | 36.6 | 55.1 | 5.1 | 19.1% | 0.10 |
| Earkart | 172 | 35.0 | 54 | 4.9 | 15.4% | 0.00 |
| Avience Biomedicals | 149 | 17.0 | 52.5 | 8.8 | 28.4% | 0.92 |
| Amkay Products | 58 | 25.3 | 42 | 2.3 | 9.2% | 0.15 |
| Galaxy Medicare | 27 | 7.9 | 40 | 3.4 | 10.6% | 0.10 |
| KMS Medisurgi | 44 | 175.3 | 12.2 | 0.3 | 7.6% | 0.09 |
| Transpact Enterprises | 4 | 45.7 | 0.2 | 0.1 | 66.7% | 0.11 |
| Median of the 10 others | 104 | 25.3 | 54.6 | 5 | 14.9% | 0.11 |
Galaxy Medicare shareholding pattern
Promoters, FIIs, DIIs, HNIs and small holdersThe promoters own more than half the company, a little more than in the first filing shown. Big foreign and Indian funds own very little. The number of shareholders is about the same.
Galaxy Medicare shareholding pattern
Per cent of shares, from the patterns filed with the exchange. Tap + to see everyone holding 1% or more in that group. HNIs and small holders show only where the pattern was filed in full.
| Sep 25 | Mar 26 | Sep 26 | |
|---|---|---|---|
| Promoters | 72.43% | 72.98% | 73.36% |
| Indian institutions (DIIs) | 1.85% | - | - |
| HNIs (over ₹2 lakh each) | 2.54% | 2.40% | 2.84% |
| Small holders (up to ₹2 lakh) | 22.20% | 21.97% | 21.12% |
| Companies and others | 0.98% | 2.65% | 2.68% |
| Number of shareholders | 856 | 867 | 821 |
The named holders are at 30 Sept 2026, beside 31 March 2026, each under the group the pattern files them in.
Galaxy Medicare latest news and announcements
Announcements · Documents · Corporate actionsWhat changed recently
Each half-year is set against the same half a year earlier
- H2 FY26: sales ₹21.3 cr (-3%), net profit ₹1.4 cr (-16%) on H2 FY25.
- Shareholding, 30 Sept 2026: promoters 72.98% to 73.36%.
Galaxy Medicare announcements
22 on record, latest first; each opens the filing on the exchange
- Quarterly Compliance Report on Corporate governance - within 21 days from the enGalaxy Medicare Limited has informed regarding Submission of Certificate in relation to Non- Applicability of Compliance Report on the Corporate Governance PursPDF ↗
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Certificate under SEBI (Depositories and Participants) Regulations, 2018PDF ↗
- Shareholders meetingSrutinizers report of Annual General Meeting held on September 28, 2026. Further, the company has informed the Exchange regarding voting resultsPDF ↗
- Shareholders meetingProceedings of Annual General Meeting held on September 28, 2026PDF ↗
- Trading WindowClosure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015PDF ↗
- Shareholders meetingNotice of Annual General Meeting to be held on September 28, 2026PDF ↗
- Record Datethat Record date for the purpose of DI is 11-Sep-2026PDF ↗
- AppointmentRe - Appointment of PBM & Associates, Chartered Accountant as Internal Auditor of the Company for the Financial Year 2026-2027 With Effect From August 31, 2026PDF ↗
- Outcome of Board Meetingoutcome of the Board Meeting held on August 31, 2026, wherein the Board approved the Notice of the 34th Annual General Meeting, including the date and time of tPDF ↗
- Reply to Clarification- Financial resultsThe Exchange had sought clarification from Galaxy Medicare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing ObligatiPDF ↗
- Quarterly Compliance Report on Corporate governance - within 21 days from the enGalaxy Medicare Limited has informed regarding Submission of Certificate in relation to Non- Applicability of Compliance Report on the Corporate Governance PursPDF ↗
- Certificate under SEBI (Depositories and Participants) Regulations, 2018Certificate under SEBI (Depositories and Participants) Regulations, 2018PDF ↗
Galaxy Medicare annual reports, earnings calls and documents
Every document links to its source; “read” marks those this page is built from
Galaxy Medicare share split, bonus and dividends
From the corporate actions the company announces on the exchange
- DividendDIVIDEND - RE 0.35 PER SHAREex-date 11 Sept 2026
- DividendINTERIM DIVIDEND - RS 0.35 PER SHAREex-date 17 Dec 2025
Checks we ran on Galaxy Medicare's data · 9
Before any number shows, it goes through the same checks. A figure that fails is held back, never shown as if it were right.
- ✓Balance sheet totals add up for FY25 and FY26.
- ✓Market cap uses the share count in the latest shareholding pattern (1,51,71,983 shares).
- ✓The share capital in the FY26 results matches the share count in the shareholding pattern.
- ✓Promoter pledge figures are within possible limits in every shareholding pattern shown.
- ✓Promoter and public holdings add up to 100% in every shareholding pattern shown.
- ✓The two half-years of FY26 add up to the full-year sales.
- !Earnings per share changes basis between FY23 (₹5.16) and FY24 (₹3.13) because the share count behind it changes; EPS is shown as reported, and growth is worked out on profit.
- ✓Revenue and profit are reported for every year shown, FY21 to FY26.
- iPrices run to the close on 14 Oct 2026, from the exchange's daily figures.
Questions people ask about Galaxy Medicare
What does Galaxy Medicare do?
Galaxy Medicare is an SME company listed on NSE Emerge, in healthcare equipment & supplies.
What is the share price of Galaxy Medicare?
₹17.7 at the close on 3 Nov 2026, from the exchange's daily figures.
What is the market cap of Galaxy Medicare?
₹27 cr at the close on 3 Nov 2026, on 1,51,71,983 shares.
What is the P/E of Galaxy Medicare?
7.9 times FY26 profit at the close on 3 Nov 2026 (our arithmetic).
What are Galaxy Medicare's revenue and profit?
Revenue ₹40 cr and profit after tax ₹3 cr in FY26.
Who are the promoters of Galaxy Medicare?
The promoter group; promoters held 73.36% at 30 Sept 2026.
What was the IPO price of Galaxy Medicare?
₹54 a share; it listed on 17 Sept 2025.
What is Galaxy Medicare's website?
www.galaxy.in
More SME companies like Galaxy Medicare
Other listed SME companies in healthcare equipment & supplies, the closest in size first, each read from its own documents.
- Royal SenseROYAL · BSE SME · Healthcare Equipment & SuppliesMarket cap ₹36 cr
- KMS MedisurgiKMSMEDI · BSE SME · Healthcare Equipment & SuppliesMarket cap ₹44 cr
- Amkay ProductsAMKAY · BSE SME · Healthcare Equipment & SuppliesMarket cap ₹46 cr
- Mohini Health & HygieneMHHL · NSE Emerge · Healthcare Equipment & Supplies · listed 2018Market cap ₹49 cr
- Avience BiomedicalsAVIENCE · NSE Emerge · Healthcare Equipment & Supplies · listed 2026Market cap ₹137 cr
- Vaidya Sane Ayurved LaboratoriesMADHAVBAUG · NSE Emerge · Healthcare Equipment & Supplies · listed 2022Market cap ₹143 cr
Every listed SME company in Healthcare Equipment & Supplies → · SME companies listed in 2025 →
Built from 22 exchange announcements, 3 shareholding patterns and 5 years of reported results. Every figure carries its source; where the documents are silent, the page says so.